CIK 0001713863 · Non-accelerated filer<br>Smaller reporting company
Rafael Holdings, Inc.
Sign in to watch- Ticker
- RFL
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jul 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822296593
- Phone
- 212-658-1450
- Business address
- 520 BROAD STREET, NEWARK, NJ, 07120
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-13 | JONAS HOWARD S Exec Chairman, CEO & President | Shares withheld for taxes | −9,905 | $1.35 | $13K | 267,707 |
| 2025-09-03 | Fine Joshua M Chief Operating Officer | Grant or award · Stock Options (right to buy) | +24,558 | 24,558 | ||
| 2025-06-21 | Polinsky David Chief Financial Officer | Shares withheld for taxes | −2,347 | $1.60 | $4K | 268,075 |
| 2025-06-13 | JONAS HOWARD S Exec Chairman, CEO & President | Grant or award | +118,596 | $2.11 | $250K | 277,612 |
| 2025-06-05 | JONAS HOWARD S Exec Chairman, CEO & President | Purchase | +457,031 | $1.28 | $585K | 457,031 |
| 2025-06-05 | JONAS HOWARD S Exec Chairman, CEO & President | Purchase | +324,219 | $1.28 | $415K | 324,219 |
| 2025-06-05 | JONAS HOWARD S Exec Chairman, CEO & President | Purchase | +12,299,207 | $1.28 | $15.7M | 12,299,207 |
| 2025-05-29 | Polinsky David Chief Financial Officer | Option exercise | +76,882 | $1.28 | $98K | 270,422 |
| 2025-05-29 | Polinsky David Chief Financial Officer | Option exercise · Class B Common Stock | −76,882 | 0 | ||
| 2025-05-27 | Sieger Markus Director | Option exercise | +35,000 | $1.28 | $45K | 190,182 |
| 2025-05-27 | Sieger Markus Director | Option exercise · Subscription Rights (right to buy) | −35,000 | 0 | ||
| 2025-03-25 | CONKLING WILLIAM Chief Executive Officer | Grant or award | +27,454 | 564,455 | ||
| 2025-03-25 | CONKLING WILLIAM Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +2,362 | 2,362 | ||
| 2025-03-25 | CONKLING WILLIAM Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +5,485 | 5,485 | ||
| 2025-03-21 | Polinsky David Chief Financial Officer | Shares withheld for taxes | −2,378 | $1.93 | $5K | 193,540 |
| 2025-03-21 | CONKLING WILLIAM Chief Executive Officer | Shares withheld for taxes | −14,814 | $1.93 | $29K | 537,001 |
| 2025-01-13 | Polinsky David Chief Financial Officer | Grant or award | +50,000 | $1.95 | $98K | 195,918 |
| 2025-01-13 | GOLDBERG JOHN CHIEF MEDICAL OFFICER | Grant or award | +50,000 | $1.95 | $98K | 50,000 |
| 2025-01-13 | CONKLING WILLIAM Chief Executive Officer | Grant or award | +60,000 | $1.95 | $117K | 551,815 |
| 2025-01-06 | GREENBERG STEPHEN M Director | Grant or award | +27,541 | $1.82 | $50K | 102,491 |
Page 2 of 6 · 120 trades